At the end of this activity, the participant will be able to:

• Understand the protocol
• Analyze the feasibility of this workflow
• Debate the constraints of this technique

Evaluation for: A trial of HDR brachytherapy single dose vs 2 fractions in a single day for intermediate prostate cancer (BRP2) Click Here